Mackay Shields LLC’s GenMark Diagnostics, Inc GNMK Stock Holding History

Mackay Shields LLC’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-51,400	Closed	-$1.23M	–	1501
2021 Q1	$1.23M	Sell	51,400 -10,000	-16%	-$186K	0.01%	942
2020 Q4	$896K	Sell	61,400 -96,300	-61%	-$1.28M	0.01%	1108
2020 Q3	$2.24M	Buy	157,700 +109,100	+224%	+$1.67M	0.02%	742
2020 Q2	$715K	Buy	+48,600	New	+$494K	0.01%	1117

Mackay Shields LLC's GNMK Position: Q2 2021 in Review

Mackay Shields LLC sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 51,400 shares — an estimated $1.23M sold.

Mackay Shields LLC first reported a position in GNMK in Q2 2020 and held it in 4 quarters. The position peaked at $2.24M in Q3 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Mackay Shields LLC reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Mackay Shields LLC sold 51,400 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.23M.
Mackay Shields LLC first reported a position in GenMark Diagnostics, Inc in Q2 2020 and held it in 4 quarters.
Mackay Shields LLC's GenMark Diagnostics, Inc position peaked at $2.24M in Q3 2020.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.